NPCE
NPCE
NASDAQ · Health Care

Neuropace Inc

$13.16
+0.32 (+2.49%)
Financial Highlights (FY 2026)
Revenue
91.02M
Net Income
-30,916,215
Gross Margin
73.9%
Profit Margin
-34.0%
Rev Growth
+20.9%
D/E Ratio
7.43
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 73.9% 73.9% 46.3% 46.3%
Operating Margin -27.1% -24.4% 8.2% 8.2%
Profit Margin -34.0% -32.3% 8.6% 7.4%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 91.02M 75.27M 354.79M 322.64M
Gross Profit 67.30M 55.65M 164.26M 149.37M
Operating Income -24,685,528 -18,371,764 29.06M 26.44M
Net Income -30,916,215 -23,008,842 30.47M 23.82M
Gross Margin 73.9% 73.9% 46.3% 46.3%
Operating Margin -27.1% -24.4% 8.2% 8.2%
Profit Margin -34.0% -32.3% 8.6% 7.4%
Rev Growth +20.9% +20.9% -3.6% +12.4%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 201.77M 201.77M 135.86M 137.71M
Total Equity 27.16M 27.16M 359.61M 343.18M
D/E Ratio 7.43 7.43 0.38 0.40
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -24,104,561 -18,936,023 37.66M 35.61M
Free Cash Flow 33.72M 30.25M